Benefits and Safety of Long-Term Use of IMR-687 As Monotherapy or in Combination with a Stable Dose of Hydroxyurea (HU) in 2 Adult Sickle Cell Patients
- Resource Type
- Abstract
- Source
- In
Blood 5 November 2020 136 Supplement 1:29-30 - Subject
- Language
- ISSN
- 0006-4971